0.9% Sodium Chloride Injection, USP Facing Active Shortage
Areazine synthesizes this Health Canada drug-shortage notice directly from Drug Shortages Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
An active shortage has been reported for 0.9% Sodium Chloride Injection, USP, according to the Drug Shortages Canada database.
What this Health Canada drug-shortage notice tells you, and what most readers miss
This notice was issued by Drug Shortages Canada on April 6, 2026 and geographically references Canada. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, canada, medication, Sodium Chloride.
What's in Shortage
The medication currently in shortage is 0.9% Sodium Chloride Injection, USP. This product is a sterile solution commonly used for fluid and electrolyte replacement. The current status of this shortage is listed as Active.
Which Manufacturers Are Affected
Specific manufacturer names, individual availability statuses, and contact information were not provided in the current source data for this report.
Why There's a Shortage
No specific reason for the shortage of 0.9% Sodium Chloride Injection, USP was provided in the official report.
What Patients Should Do
If you are a patient or caregiver concerned about the availability of this medication, please take the following steps:
- Consult Your Healthcare Provider: Speak with your doctor or the medical staff at your treatment facility to discuss how this shortage may affect your care.
- Talk to a Pharmacist: Clinical or hospital pharmacists can provide information on current stock levels and any institutional protocols for managing supply.
- Contact the Manufacturer: If manufacturer details become available, you may contact them directly for specific supply timelines.
Disclaimer: This article is for informational purposes only. Patients should always consult with their healthcare provider or a qualified medical professional regarding their treatment and any potential medication shortages.
Source
Information provided by the Drug Shortages Canada database (Shortage ID: 94411).
Original source: Drug Shortages Canada Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,520 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 6, 2026.
Frequently Asked Questions
Common questions about this Health Canada drug-shortage notice.